Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Thomas Jefferson University
Pfizer
Thomas Jefferson University
Mayo Clinic
Rutgers, The State University of New Jersey
Ethicon, Inc.
Wake Forest University Health Sciences
Pheon Therapeutics
National Cancer Institute (NCI)
Xemed LLC
Pfizer
Takeda
Ethicon, Inc.
Mayo Clinic
M.D. Anderson Cancer Center
University of Kentucky
Tempus AI
Mayo Clinic
Sanofi
University of Southern California
Korea University Guro Hospital
Novartis
Galvanize Therapeutics, Inc.
Washington University School of Medicine
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Formycon AG
Massachusetts General Hospital
NRG Oncology
Vanderbilt-Ingram Cancer Center
ImmunoGenesis
University of Maryland, Baltimore
Duke University
University of Kentucky
Faeth Therapeutics
NextCure, Inc.
Abramson Cancer Center at Penn Medicine
Roswell Park Cancer Institute
Bristol-Myers Squibb
Novartis
Elevation Oncology
Fundación GECP
Checkpoint Therapeutics, Inc.
The University of Hong Kong
Blueprint Medicines Corporation
Blueprint Medicines Corporation